Trading Signals: BNTX Stock Price Prediction and Forecast (Thu. Oct. 10, 2019 - Fri. Dec. 22, 2023)(BioNTech SE )
| Market is closed on Mon. Feb. 19, 2024 | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 0% (three month average) | | RSI | | | Latest Price | $(0%) | | Stocks Behave Similarly | Similar Stock List | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support BNTX advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting BNTX price | BNTX will advance at least -0% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | 0% (StdDev 0%) | | Hourly BBV | 0 () | | Intraday Trend | NAN% | | | | | |
|
BioNTech SE operates as a clinical-stage biotechnology company. It operates through the following business units: Biotech Business and External Services. The Biotech Business unit consists of Clinical, Technology Platform and Manufacturing segments. It also includes business services operations. The External Services unit consists of External Services segment, which includes activities related to the sale of diagnostic products, peptides, retroviral vectors for clinical supply, development and manufacturing services. The company was founded by Christopher Huber, Ozlem Tureci and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany. July 1, 2020. BioNTech and Pfizer have released the most detailed information so far among the vaccine candidates being tested in the U.S., 24 participants in the Phase 1/2 clinical trial who received two doses of the lower-dose vacc.ines developed neutralizing antibodies. |